Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00242827 · ClinicalTrials.gov registry record · Phase 2
Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma
A Phase 2 study, sponsored by Cephalon.
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00242827: Clinical Trial Phase 2 study, sponsored by Cephalon.
NCT00242827 is a Phase 2 study that was terminated before completion, run by Cephalon. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00242827, a Phase 2 study, was terminated before completion, sponsored by Cephalon.
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
Interventions
- DRUG Oral CEP-701
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-04 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
Why NCT00242827 stopped before completion
NCT00242827 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Oral CEP-701 is the first listed.
NCT00242827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00242827 about?
NCT00242827 is a clinical study titled "Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma". An Open-Label Study of the Efficacy and Safety of Oral CEP-701 for the Treatment of Patients with Advanced Multiple Myeloma.
What is the current status of trial NCT00242827?
This trial is currently terminated. It is a Phase 2 study. The study started on 2006-04. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00242827?
The interventions under investigation include: Oral CEP-701 (DRUG).
Who is sponsoring clinical trial NCT00242827?
This trial is sponsored by Cephalon, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia